DFA
IGC icon

DHJJ Financial Advisors’s IGC Pharma IGC Stock Holding History

DHJJ Financial Advisors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22 Hold
80
– – ﹤0.01% 1078
2026
Q1 		$22 Hold
80
– – ﹤0.01% 1076
2025
Q4 		$23 Hold
80
– – ﹤0.01% 1036
2025
Q3 		$34 Hold
80
– – ﹤0.01% 994
2025
Q2 		$25 Hold
80
– – ﹤0.01% 967
2025
Q1 		$23 Hold
80
– – ﹤0.01% 924
2024
Q4 		$27 Hold
80
– – ﹤0.01% 890
2024
Q3 		$35 Hold
80
– – ﹤0.01% 868
2024
Q2 		$35 Hold
80
– – ﹤0.01% 823
2024
Q1 		$32 Hold
80
– – ﹤0.01% 807
2023
Q4 		$23 Hold
80
– – ﹤0.01% 797
2023
Q3 		$29 Buy
+80
New +$29 ﹤0.01% 791

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $145M AUM 29.71% 1-Year Est. Return

DHJJ Financial Advisors's IGC Position: Q2 2026 in Review

DHJJ Financial Advisors held its IGC Pharma (IGC) position steady in Q2 2026 at 80 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

DHJJ Financial Advisors first reported a position in IGC in Q3 2023 and has held it in 12 quarters since. The position peaked at $35 in Q3 2024. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • DHJJ Financial Advisors held 80 shares of IGC Pharma worth $22 as of Q2 2026.
  • DHJJ Financial Advisors left its IGC Pharma share count unchanged in Q2 2026.
  • IGC Pharma made up ﹤0.01% of DHJJ Financial Advisors's portfolio in Q2 2026, its #1078 holding.
  • DHJJ Financial Advisors first reported a position in IGC Pharma in Q3 2023 and has held it in 12 quarters since.
  • DHJJ Financial Advisors's IGC Pharma position peaked at $35 in Q3 2024.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on DHJJ Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.